ADVERTISEMENT

Poisoning

SERB And BTG SP – A Simple Jigsaw

SERB And BTG SP – A Simple Jigsaw

The merging of the capabilities of Belgium’s SERB and the UK’s BTG Specialty Pharma could produce the world’s biggest antidotes manufacturer.

BTG SP Makes A Virtue Of Manufacturing And Supply Discipline Despite COVID

BTG SP Makes A Virtue Of Manufacturing And Supply Discipline Despite COVID

Manufacturing and supply chain resilience ensured that BTG Specialty Pharma met its sales target in the COVID-affected 2020. Its president, Anthony Higham, explained how this was possible while the company busily  ̶  and quietly – sought new ownership, and all under the shadow of Brexit.

SERB Pays $800m For Boston Scientific Specialty Pharma Business

SERB Pays $800m For Boston Scientific Specialty Pharma Business

The sale of BTG Specialty Pharmaceuticals to two affiliates of European specialty firm SERB leaves Boston Scientific with BTG’s interventional oncology and vascular products.

 £80m To Tackle Snakebite Is A Wellcome Boost

£80m To Tackle Snakebite Is A Wellcome Boost

Two major initiatives have been announced which hope to revolutionize the treatment of snakebites, which claims the lives of up to 138,000 people a year.

Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue

Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue

Harm Reduction Therapeutics, which has sought funding for a US Rx-to-OTC new drug application, receives grant from Purdue Pharma that enables filing and launching the product in a targeted 100,000 retail locations within two years.

Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue

Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue

Harm Reduction Therapeutics, which has sought funding for a US Rx-to-OTC new drug application, receives grant from Purdue Pharma that enables filing and launching the product in a targeted 100,000 retail locations within two years.

Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue

Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue

FDA and FTC send joint warning letters to 11 US firms about 12 products marketed as unapproved drugs with claims about aiding in the treatment of opioid addiction and withdrawal. FDA also thanks CSPI for suggesting the agencies investigate a scourge of fraudulent drug-abuse withdrawal claims.

Indivior Pact Buys Addex Time For Progressing Dipraglurant And Pipeline

Indivior Pact Buys Addex Time For Progressing Dipraglurant And Pipeline

Addex Therapeutics says its licensing deal with Indivior to develop and commercialize its investigative addiction therapy ADX71441 'buys time' to find resources for progressing its own pipeline.

Guidance On Acetaminophen Allergy Warning Trails Industry's Change

Guidance On Acetaminophen Allergy Warning Trails Industry's Change

Final US guidance adds CHPA's suggestion for an example for a warning on labeling for products containing both acetaminophen and aspirin, needed to highlight where “Allergy Alert” and “Liver Warning” statements are on those products' labels.

Guidance On Acetaminophen Allergy Warning Trails Industry's Change

Guidance On Acetaminophen Allergy Warning Trails Industry's Change

Final US guidance adds CHPA's suggestion for an example for a warning on labeling for products containing both acetaminophen and aspirin, needed to highlight where “Allergy Alert” and “Liver Warning” statements are on those products' labels.